Business Context and Reporting Period
Company: Phibro Animal Health Corporation (PAHC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 26, 2026
Reporting Period: Fourth quarter and fiscal year ended June 30, 2026.
Context: The filing announces operating results for the fiscal year ended June 30, 2026, and provides financial guidance for the fiscal year ending June 30, 2027.
Key Financial Metrics
The provided text serves as a cover sheet and index for the 8-K filing. It references a press release (Exhibit 99.1) containing the specific financial data but does not list the numerical values within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in the filing text; contained in the attached press release.
- Debt and Liquidity: Not provided in the filing text; contained in the attached press release.
Material Changes
The filing text does not detail specific material changes or comparative performance metrics versus prior periods. It only confirms the issuance of results for the period ended June 30, 2026.
Guidance, Outlook, and Risks
- Guidance: Management has issued financial guidance for the fiscal year ending June 30, 2027, as detailed in the attached press release.
- Risks and Contingencies: No specific risks or contingencies are described in the text of this 8-K summary.
- Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 26, 2026) for actual revenue, earnings, and cash flow figures.
- Verify the specific numerical targets included in the guidance for fiscal year 2027.
- Confirm the EPS and revenue growth rates for the fourth quarter and full fiscal year 2026 against prior year performance.
- Check for any non-GAAP reconciliations or adjustments mentioned in the full press release.